Metabolomics: the apogee of the omics trilogy

Smith, C. A., Want, E. J., O'Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779–787 (2006).

Patti, G. J. et al. Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome. Neuroscience 170, 858–864 (2010).

Koizumi, S. et al. Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain. Neuroscience 168, 219–225 (2010).

Baker, M. Metabolomics: from small molecules to big ideas. Nature Methods 8, 117–121 (2011).

Kind, T., Scholz, M. & Fiehn, O. How large is the metabolome? A critical analysis of data exchange practices in chemistry. PLoS ONE 4, e5440 (2009).

Dudley, E., Yousef, M., Wang, Y. & Griffiths, W. J. Targeted metabolomics and mass spectrometry. Adv. Protein Chem. Struct. Biol. 80, 45–83 (2010).

Nicholson, J. K., Connelly, J., Lindon, J. C. & Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nature Rev. Drug Discov. 1, 153–161 (2002).

Dirren, H., Robinson, A. B. & Pauling, L. Sex-related patterns in the profiles of human urinary amino acids. Clin. Chem. 21, 1970–1975 (1975).

Davison, J. M. & Cheyne, G. A. History of the measurement of glucose in urine: a cautionary tale. Med. Hist. 18, 194–197 (1974).

Robinson, A. B. & Robinson, N. E. Origins of metabolic profiling. Methods Mol. Biol. 708, 1–23 (2011).

Dalgliesh, C. E., Horning, E. C., Horning, M. G., Knox, K. L. & Yarger, K. A gas-liquid-chromatographic procedure for separating a wide range of metabolites occuring in urine or tissue extracts. Biochem. J. 101, 792–810 (1966).

Eknoyan, G. Santorio Sanctorius (1561–1636) —founding father of metabolic balance studies. Am. J. Nephrol. 19, 226–233 (1999).

Astarita, G., Ahmed, F. & Piomelli, D. Lipidomic analysis of biological samples by liquid chromatography coupled to mass spectrometry. Methods Mol. Biol. 579, 201–219 (2009).

Want, E. J. et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78, 743–752 (2006).

Yanes, O., Tautenhahn, R., Patti, G. J. & Siuzdak, G. Expanding coverage of the metabolome for global metabolite profiling. Anal. Chem. 83, 2152–2161 (2011).

Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A. & Wu, M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta 1807, 726–734 (2011).

Buxton, D. B., Schwaiger, M., Nguyen, A., Phelps, M. E. & Schelbert, H. R. Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ. Res. 63, 628–634 (1988).

Bajad, S. U. et al. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. J. Chromatogr. A 1125, 76–88 (2006).

Bennett, B. D. et al. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nature Chem. Biol. 5, 593–599 (2009).

Buescher, J. M., Moco, S., Sauer, U. & Zamboni, N. Ultrahigh performance liquid chromatography-tandem mass spectrometry method for fast and robust quantification of anionic and aromatic metabolites. Anal. Chem. 82, 4403–4412 (2010).

Sabatine, M. S. et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112, 3868–3875 (2005).

Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nature Med. 17, 448–453 (2011).

Shaham, O. et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 4, 214 (2008).

Barton, R. H., Nicholson, J. K., Elliott, P. & Holmes, E. High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int. J. Epidemiol. 37 (Suppl. 1), I31–I40 (2008).

Buscher, J. M., Czernik, D., Ewald, J. C., Sauer, U. & Zamboni, N. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal. Chem. 81, 2135–2143 (2009).

Jonsson, P. et al. Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst 130, 701–707 (2005).

Nordstrom, A., Want, E., Northen, T., Lehtio, J. & Siuzdak, G. Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Anal. Chem. 80, 421–429 (2008).

Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698–3703 (2009).

Yanes, O. et al. Metabolic oxidation regulates embryonic stem cell differentiation. Nature Chem. Biol. 6, 411–417 (2010).

Baran, R. et al. MathDAMP: a package for differential analysis of metabolite profiles. BMC Bioinformatics 7, 530 (2006).

Lommen, A. MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal. Chem. 81, 3079–3086 (2009).

Katajamaa, M., Miettinen, J. & Oresic, M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22, 634–636 (2006).

Katajamaa, M. & Oresic, M. Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics 6, 179 (2005).

Tautenhahn, R., Bottcher, C. & Neumann, S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 9, 504 (2008).

Beadle, G. W. & Tatum, E. L. Genetic control of biochemical reactions in neurospora. Proc. Natl Acad. Sci. USA 27, 499–506 (1941).

Tatum, E. L. & Beadle, G. W. Genetic control of biochemical reactions in neurospora: an “Aminobenzoicless” mutant. Proc. Natl Acad. Sci. USA 28, 234–243 (1942).

Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54–60 (2011).

Nicholson, G. et al. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol. Syst. Biol. 7, 525 (2011).

Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genomics 2, 155–168 (2001).

Trauger, S. A. et al. Correlating the transcriptome, proteome, and metabolome in the environmental adaptation of a hyperthermophile. J. Proteome Res. 7, 1027–1035 (2008).

Kirschner, M. W. The meaning of systems biology. Cell 121, 503–504 (2005).

Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).

Dong, M. Q. et al. Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science 317, 660–663 (2007).

Kang, S., Bader, A. G. & Vogt, P. K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc. Natl Acad. Sci. USA 102, 802–807 (2005).

Villas-Boas, S. G., Hojer-Pedersen, J., Akesson, M., Smedsgaard, J. & Nielsen, J. Global metabolite analysis of yeast: evaluation of sample preparation methods. Yeast 22, 1155–1169 (2005).

Wittmann, C., Kromer, J. O., Kiefer, P., Binz, T. & Heinzle, E. Impact of the cold shock phenomenon on quantification of intracellular metabolites in bacteria. Anal. Biochem. 327, 135–139 (2004).

Patti, G. J. Separation strategies for untargeted metabolomics. J. Sep. Sci. 34, 3460–3469 (2011).

Lu, W. et al. Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal. Chem. 82, 3212–3221 (2010).

Han, X. & Gross, R. W. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24, 367–412 (2005).

Wolters, D. A., Washburn, M. P. & Yates, J. R. 3rd. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73, 5683–5690 (2001).

Melamud, E., Vastag, L. & Rabinowitz, J. D. Metabolomic analysis and visualization engine for LC-MS data. Anal. Chem. 82, 9818–9826 (2010).

Wishart, D. S. et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603–D610 (2009).

Forsythe, I. J. & Wishart, D. S. Exploring human metabolites using the human metabolome database. Curr. Protoc. Bioinformatics Ch. 14, Unit 14.8 (2009).

Smith, C. A. et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747–751 (2005).

Patti, G. J., Tautenhahn, R. & Siuzdak, G. Meta-analysis of untargeted metabolomic data from multiple profiling experiments. Nature Protoc. 7, 508–516 (2012).

Tautenhahn, R. et al. metaXCMS: second-order analysis of untargeted metabolomics data. Anal. Chem. 83, 696–700 (2011).

Bottomley, P. A., Hardy, C. J. & Roemer, P. B. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn. Reson. Med. 14, 425–434 (1990).

Golman, K., Zandt, R. I., Lerche, M., Pehrson, R. & Ardenkjaer-Larsen, J. H. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 66, 10855–10860 (2006).

Cakmakci, H., Pekcevik, Y., Yis, U., Unalp, A. & Kurul, S. Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature. Eur. J. Radiol. 74, e161–e171 (2010).

Greving, M. P., Patti, G. J. & Siuzdak, G. Nanostructure-initiator mass spectrometry metabolite analysis and imaging. Anal. Chem. 83, 2–7 (2011).

Northen, T. R. et al. Clathrate nanostructures for mass spectrometry. Nature 449, 1033–1036 (2007).

Woo, H. K., Northen, T. R., Yanes, O. & Siuzdak, G. Nanostructure-initiator mass spectrometry: a protocol for preparing and applying NIMS surfaces for high-sensitivity mass analysis. Nature Protoc. 3, 1341–1349 (2008).

Rabinowitz, J. D., Purdy, J. G., Vastag, L., Shenk, T. & Koyuncu, E. Metabolomics in drug target discovery. Cold Spring Harb. Symp. Quant. Biol. 23 Nov 2011 (doi:10.1101/sqb.2011.76.010694).

Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009).

Patti, G. J. et al. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nature Chem. Biol. 8, 232–234 (2012).

Saghatelian, A. et al. Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43, 14332–14339 (2004).

Clasquin, M. F. et al. Riboneogenesis in yeast. Cell 145, 969–980 (2011).

de Carvalho, L. P. et al. Activity-based metabolomic profiling of enzymatic function: identification of Rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase. Chem. Biol. 17, 323–332 (2010).

Feynman, R. P., Leighton, R. B. & Sands, M. L. The Feynman Lectures on Physics (Addison-Wesley Publishing Company, Boston, 1963).

Segre, E. From X-rays to Quarks: Modern Physicists and Their Discoveries (Dover Publications, New York, 2007).